Ignite Creation Date:
2025-12-26 @ 11:00 AM
Ignite Modification Date:
2026-04-23 @ 4:19 AM
Study NCT ID:
NCT05876806
Status:
RECRUITING
Last Update Posted:
2023-11-30
First Post:
2023-05-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dabrafenib Plus Trametinib in Patients With Advanced Solid Tumor Having BRAF V600E Mutation or Clinically Actionable BRAF Gene Alterations
Sponsor:
Se Jun Park
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
BROAD
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None